Technavio expects global psoriatic arthritis market to surpass $3.5 billion by 2019
This market analysis by Technavio segments the global psoriatic arthritis market by mechanism of action (TNF inhibitors, PDE4 inhibitors, interleukin blockers, and others), by type of molecule (biologics and small molecules), by type of disease (mild psoriatic arthritis, moderate psoriatic arthritis, and severe psoriatic arthritis), by route of administration (oral, parenteral, and topical), by…